Evidence map›Paper›PMID 23007646›Full record

ArticleThe Journal of cell biology2012

PML promotes MHC class II gene expression by stabilizing the class II transactivator.

Tobias Ulbricht, Mohammad Alzrigat, Almut Horch, Nina Reuter, Anna von Mikecz, Viktor Steimle, Eberhard Schmitt, Oliver H Krämer, Thomas Stamminger, Peter Hemmerich

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Tobias UlbrichtLeibniz Institute for Age Research, Fritz-Lipmann Institute, 07745 Jena, Germany.
Mohammad Alzrigat
Almut Horch
Nina Reuter
Anna von Mikecz
Viktor Steimle
Eberhard Schmitt
Oliver H Krämer
Thomas Stamminger
Peter Hemmerich
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DEUniversitätsklinikum Erlangen · DECarl Zeiss (Germany) · DEFriedrich Schiller University Jena · DEKirchhoff (Germany) · DELeibniz Institute of Environmental Medicine · DEUniversité de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Promyelocytic leukemia (PML) nuclear bodies selectively associate with transcriptionally active genomic regions, including the gene-rich major histocompatibility (MHC) locus. In this paper, we have explored potential links between PML and interferon (IFN)-γ-induced MHC class II expression. IFN-γ induced a substantial increase in the spatial proximity between PML bodies and the MHC class II gene cluster in different human cell types. Knockdown experiments show that PML is required for efficient IFN-γ-induced MHC II gene transcription through regulation of the class II transactivator (CIITA). PML mediates this function through protection of CIITA from proteasomal degradation. We also show that PML isoform II specifically forms a stable complex with CIITA at PML bodies. These observations establish PML as a coregulator of IFN-γ-induced MHC class II expression.

Indexed as

Cells, CulturedGene Expression ProfilingGenes, MHC Class IIHumansInterferon-gammaNuclear ProteinsPromyelocytic Leukemia ProteinTrans-ActivatorsTranscription FactorsTumor Suppressor ProteinsInterferon-gammaMHC class II transactivator proteinNuclear ProteinsPML protein, humanPromyelocytic Leukemia ProteinTrans-ActivatorsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID23007646
PMCPMC3461510
OpenAlexW2165991852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.